Provided by Tiger Trade Technology Pte. Ltd.

Aesthetic Medicine

888.238
-1.846-0.21%
Number of Gainers:7
Number of Losers:3
Number of Flat:3
PE:- -
High:891.531
Open:889.747
Low:879.542
Close:890.084
Volume:36.86M
Turnover:396.29M
Market Cap:148.45B
Float Cap:108.83B

Loading ...

JPMorgan Raises Stake in Angelalign with Recent Share Acquisition

Stock News
·
Yesterday

Fosun Pharma Spends HK$22.24 Million to Buy Back 1.3 Million Shares

Stock News
·
Yesterday

AH Share Premium Rankings Update: September 16 Market Close

Stock News
·
Yesterday

Lazard Asset Management Raises Stake in CMS with 1.265 Million Share Purchase

Deep News
·
Yesterday

Fosun Pharma Spends HK$22.07 Million on Share Buyback on September 15

Stock News
·
Sep 15

China Medical System Gets China Nod for Lupus Erythematosus Drug Trial

MT Newswires
·
Sep 14

CMS Secures Clinical Trial Green Light for Innovative Lupus Treatment Candidate

Stock News
·
Sep 14

China Medical System Holdings - CMS-D001 Granted Drug Clinical Trial Approval Notice by Nmpa on Sept 11, 2026

THOMSON REUTERS
·
Sep 14

3SBIO Allocates HK$3.09 Million to Buy Back 200,000 Shares

Stock News
·
Sep 14

Fosun Pharma Spends HK$24.7 Million Buying Back 1.455 Million Shares on September 14

Stock News
·
Sep 14

AH Share Premium Rankings as of September 14

Stock News
·
Sep 14

HK Stocks in Focus: Innovative Drug Sector Surges on WCLC Data Boost, Analysts See Value After Pullback

Stock News
·
Sep 14

Chinese Drug Regulator Accepts Fosun Pharma's Application for HLX14; Shares Up 5%

MT Newswires Live
·
Sep 14

Longchuan Zone of Ruili Industrial Cooperation Park Reports Strong Performance in First Half

Deep News
·
Sep 12

Angelalign Announces Extraordinary General Meeting

Reuters
·
Sep 11

Angelalign Shareholders to Vote on 1,255,803 RSU Grants to Three Executive Directors at Sept. 30 EGM

Reuters
·
Sep 11

Angelalign Grants 1.56 Million Restricted Share Units to Eligible Participants

Stock News
·
Sep 11

Fosun Pharma's Subsidiary Sees Regulatory Acceptance for Denosumab Biosimilar Candidate HLX14

Stock News
·
Sep 11

Fosun Pharma Spends Approximately HK$21.86 Million on Share Buyback

Stock News
·
Sep 11

3SBio Allocates HK$62.6 Million to Buy Back 4 Million Shares

Stock News
·
Sep 10